Results 101 to 110 of about 9,897,716 (146)

Evaluating the inhibitory effect of resveratrol on the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice. [PDF]

Front Pharmacol, 2023
El-Sayed SAE, El-Alfy ES, Sayed-Ahmed MZ, Mohanta UK, Alqahtani SS, Alam N, Ahmad S, Ali MS, Igarashi I, Rizk MA.   +9 more
europepmc   +1 more source

The Pleiotropic Roles of Cytokines in Chimeric Antigen Receptor T-cell Therapy. [PDF]

Cancer Immunol Res
Stewart CM, Siegler EL, Kenderian SS.
europepmc   +1 more source

CAR T-cell product performance in haematological malignancies before and after marketing authorisation. [PDF]

Lancet Oncol, 2020
Elsallab M, Levine BL, Wayne AS, Abou-El-Enein M.   +3 more
europepmc   +1 more source

SEOM-GOTEL clinical guidelines on diffuse large B-cell lymphoma (update 2025). [PDF]

Clin Transl Oncol
Gumà J, Palazón-Carrión N, Rueda-Domínguez A, Sequero S, Calvo V, García-Arroyo R, Gómez-Codina J, Llanos M, Martínez-Banaclocha N, Provencio M.   +9 more
europepmc   +1 more source

Incorporating mRNA therapeutics into biological treatments of hematologic malignancies. [PDF]

Front Immunol
Hunia J, Tomasik J, Czerwik N, Pezeshki PS, Nowis D.   +4 more
europepmc   +1 more source

MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications. [PDF]

Curr Hematol Malig Rep
Tran V, Salafian K, Michaels K, Jones C, Reed D, Keng M, El Chaer F.   +6 more
europepmc   +1 more source

Enhancing CAR-T Efficacy in Large B-Cell Lymphoma with Radiation Bridging Therapy: A Real-World Single-Center Experience. [PDF]

Curr Oncol
Laverdure E, Mollica L, Ahmad I, Cohen S, Lachance S, Veilleux O, Bernard M, Marchand EL, Delisle JS, Bernard L, Boileau M, Petrella T, Pilon SJ, Bouchard P, Roy DC, Busque L, Fleury I.   +16 more
europepmc   +1 more source

Immunotherapy of Hematological Malignancies of Human B-Cell Origin with CD19 CAR T Lymphocytes. [PDF]

Cells
Khvorost D, Kendall B, Jazirehi AR.
europepmc   +1 more source

Furamidine, a methyltransferase inhibitor, is a potential anti-Babesia spp. chemotherapeutic. [PDF]

Parasitol Res
Liang Q, Li X, Zhang X, Zhang Y, Wang J, Liu Z, Ye Y, Bai Y, Zhao S, Luo J, You C, Yin H, Guan G.   +12 more
europepmc   +1 more source

Consensus statements for the biopsychosocial care of patients with epidermolysis bullosa South Africa: Part 2. [PDF]

Health SA
Chateau AV, Blackbeard D, Hlela C, Wege M, Armour A, Naicker T, Dlova N, Foolchand S, Chetty A, Ainsworth S, Shaw CM, Lachman R, Kruse CH, Rajkumar K, Mare P, Mchiza A, Shanahan H, Roberts T, Kauchali S, Aldous C.   +19 more
europepmc   +1 more source